Galapagos | GLPG - Loan Capital



Galapagos reported EUR6.05M in Loan Capital for its fiscal quarter ending in June of 2025.


Loan Capital Change Date
argenx SE 35.57M 32.76M Jun/2025
AstraZeneca USD 25.99B 1.9B Jun/2025
Biogen USD 6.28B 1.74B Jun/2025
Genmab DKK 132M 3M Jun/2025
Gilead Sciences USD 22.14B 6M Jun/2025
GlaxoSmithKline GBP 15.3B 1.17B Jun/2025
GRIFOLS EUR 7.45B 1.94B Jun/2025
Hikma Pharmaceutical USD 607M 454M Dec/2024
Incyte USD 31.76M 883K Jun/2025
Merck EUR 6.3B 665M Jun/2025
Neurocrine Biosciences USD 0 0 Dec/2024
Novartis USD 24.06B 2.4B Jun/2025
Roche Holding CHF 32.1B 1.94B Dec/2024
Sanofi 13.2B 211M Jun/2025
UCB EUR 2.96B 21M Dec/2024
Vertex Pharmaceuticals USD 112.8M 1.2M Dec/2024